← Eichor
Condition: Immune Deficiencies Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Immune Deficiencies

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Exploratory Clinical Study on the Safety and Efficacy of Targeted BCMA Autologous CART Cell Injection in Subjects With R
NA · 1 location(s) · Beijing Boren Hospital · NCT06983951A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, an
Phase 2 · 5 location(s) · GlaxoSmithKline · NCT07224672Investigating the Pathogenic Role of N-glycosylation in AL Amyloidosis: Molecular Bases, Diagnosis, and Treatment
Phase N/A · 1 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT07448779Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagn
Phase 3 · 117 location(s) · SWOG Cancer Research Network · NCT06022939Daratumumab Maintenance Therapy for Improving Survival in Patients With Light Chain Amyloidosis, EMILIA Trial
Phase 2 · 2 location(s) · Mayo Clinic · NCT05898646A EUropean REgistry and Sample Sharing networK to Promote the Diagnosis and Management of Light Chain Amyloidosis (EUREK
Phase N/A · 6 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT06205953Safety and Efficacy of Metabolically Armed BCMA CAR-T Cells (Meta10-BCMA) in the Treatment of r/r Plasma Cell Neoplasms
EARLY_Phase 1 · 1 location(s) · Anhui Provincial Hospital · NCT07085559The Norwegian Immunotherapy in Multiple Myeloma Study
Phase N/A · 23 location(s) · St. Olavs Hospital · NCT06855121FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases
Phase N/A · 1 location(s) · xCures · NCT06539169Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry
Phase N/A · 1 location(s) · University of Alabama at Birmingham · NCT05556928Essen Amyloidosis Registry
Phase N/A · 1 location(s) · University Hospital, Essen · NCT06887283Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
Phase 1/Phase 2 · 3 location(s) · Ashvattha Therapeutics, Inc. · NCT05395624A Phase 1 Study of 99mTc-p5+14 in Healthy Volunteers and Patients With AL or ATTR Systemic Amyloidosis
Phase 1 · 1 location(s) · University of Tennessee Graduate School of Medicine · NCT05951816AIM's Writing for Healing: A Workshop for Individuals Living With Paralysis
Phase N/A · 1 location(s) · University of Alabama at Birmingham · NCT04721717Prospective Study of Teclistamab in the Treatment of Systemic AL Amyloidosis
NA · 2 location(s) · Peking University People's Hospital · NCT06699394Study of GC012F, CAR-T Therapy Targeting CD19 and BCMA in Chinese Participants With Relapsed or Refractory AL Amyloidosi
Phase 1 · 9 location(s) · Gracell Biotechnologies (Shanghai) Co., Ltd. · NCT07250269Studies of Disorders With Increased Susceptibility to Fungal Infections
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT01222741Registry of Older Patients With Cancer
Phase N/A · 7 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT01137825Repeat PET/CT Imaging in People With CAPS and Anakinra-Induced Amyloidosis Using an Amyloid-Reactive Peptide to Measure
Phase 1 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06974877Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE)
Phase 2 · 1 location(s) · University of Alabama at Birmingham · NCT04991103The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Tr
Phase 2 · 1 location(s) · Mayo Clinic · NCT07285044A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light
Phase 1 · 29 location(s) · Janssen Research & Development, LLC · NCT05652335Detection and Characterization of Infections and Infection Susceptibility
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00404560ALS Research Collaborative
Phase N/A · 1 location(s) · ALS Therapy Development Institute · NCT06885918Retinal Imaging in Neurodegenerative Disease
Phase N/A · 1 location(s) · Duke University · NCT03233646The Italian Transthyretin Amyloidosis Web-Network
Phase N/A · 30 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT05444920Teclistamab in Previously Treated AL Amyloidosis
Phase 2 · 1 location(s) · Peking Union Medical College Hospital · NCT06935162Autologous BCMA-targeted CAR-T Cell Injection for Relapsed/Refractory Light Chain Amyloidosis
EARLY_Phase 1 · 1 location(s) · Beijing Boren Hospital · NCT07626476A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH
Phase N/A · 1 location(s) · Peking University First Hospital · NCT05283993Daratumumab for Patients With Light Chain Amyloidosis
NA · 1 location(s) · Nanjing University School of Medicine · NCT06376214
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.